Skip to main content
. 2008 Dec 17;3(12):e3959. doi: 10.1371/journal.pone.0003959

Figure 11. Model for statin action.

Figure 11

Proposed model for statin interaction with the TGF-β/Smad pathway in atherosclerosis. In normal conditions TRII and TGF-β expression is regulated by RhoA through ROCK activation. Hyperactivation of RhoA in pathological condition may lead to the downregulation of TRII and TGF-β that characterizes unstable plaques. Statins inhibit prenylation of RhoA, thus increasing TRII expression and TGF- β release. The TRII upregulation allows TGF-β present in serum or induced by statins to activate the Smad pathway and increase ECM proteins production. These effects may promote plaque stability.